| Literature DB >> 29445335 |
Christian Beste1, Moritz Mückschel1,2, Madlen Paucke2, Tjalf Ziemssen2.
Abstract
The monitoring of cognitive functions is central to the assessment and consecutive management of multiple sclerosis (MS). Though, especially cognitive processes that are central to everyday behavior like dual-tasking are often neglected. We examined dual-task performance using a psychological-refractory period (PRP) task in N = 21 patients and healthy controls and conducted standard neuropsychological tests. In dual-tasking, MS patients committed more erroneous responses when dual-tasking was difficult. In easier conditions, performance of MS patients did not differ to controls. Interestingly, the response times were generally not affected by the difficulty of the dual task, showing that the deficits observed do not reflect simple motor deficits or deficits in information processing speed but point out deficits in executive control functions and response selection in particular. Effect sizes were considerably large with d∼0.80 in mild affected patients and the achieved power was above 99%. There are cognitive control and dual tasking deficits in MS that are not attributable to simple motor speed deficits. Scaling of the difficulty of dual-tasking makes the test applied suitable for a wide variety of MS-patients and may complement neuropsychological assessments in clinical care and research setting.Entities:
Keywords: behavior; dual task; executive function; multiple sclerosis; psychological refractory period
Year: 2018 PMID: 29445335 PMCID: PMC5797790 DOI: 10.3389/fnhum.2018.00024
Source DB: PubMed Journal: Front Hum Neurosci ISSN: 1662-5161 Impact factor: 3.169
Results of neuropsychological testing and demographical data of the MS patient group and the healthy control group.
| MS patients | Control group | ||||
|---|---|---|---|---|---|
| Age | 39.76 (12.29) | 29.52 (5.89) | 3.44 | 0.001* | 1.05 |
| Education (years in school) | 11.34 (0.97) | 11.62 (0.8) | –1.04 | 0.304 | –0.33 |
| Years since diagnosis | 13.06 (7.41) | N/A | |||
| Age relative to years since diagnosis | 6.09 (3.84) | N/A | |||
| Beck Depression Inventory (BDI) | 13.95 (10.44) | 7.05 (6.81) | 2.54 | 0.015* | 0.81 |
| Expanded Disability Status Scale (EDSS) | 3.32 (1.78) | N/A | |||
| MS Medication ( | |||||
| Copaxone | 2 | N/A | |||
| Fingolimod | 3 | N/A | |||
| Tysabri | 6 | N/A | |||
| Other | 7 | N/A | |||
| none | 3 | N/A | |||
| Modified Fatigue Impact Scale (MFIS) | 34.15 (23.59) | 21.86 (11.89) | 2.08 | 0.044* | 0.72 |
| Sex ( | 16 female/5 male | 12 female/9 male | |||
| Type of MS ( | |||||
| Relapsing Remitting MS (RRMS) | 17 | N/A | |||
| Secondary Progressive MS (SPMS) | 4 | N/A | |||
| Test of Attentional Performance (TAP) | |||||
| Alertness median RT | 303.1 (89.68) | 252.5 (44.53) | –2.32 | 0.026* | –0.73 |
| Intrinsic alertness median (T) | 40.24 (8.22) | 46.05 (8.09) | –2.31 | 0.026* | –0.75 |
| Phasic arousal median (T) | 39.71 (6.10) | 44.05 (6.06) | –2.31 | 0.026* | –0.83 |
| Working memory level 3 error (T) | 53.57 (5.69) | 53.29 (6.41) | 0.153 | 0.879 | 0.05 |
| Working memory level 3 median (T) | 45.43 (9.69) | 49.52 (8.79) | –1.44 | 0.159 | –0.46 |
| Divided attention auditory median (T) | 36.52 (7.10) | 45.50 (8.89) | –3.58 | 0.001* | –1.19 |
| Divided attention visual median (T) | 46.05 (8.82) | 55.65 (6.88) | –3.88 | <0.001* | –1.11 |
| Divided attention error (T) | 47.24 (8.71) | 49.65 (7.18) | –0.965 | 0.341 | –0.26 |
| Divided attention misses (T) | 47.48 (8.19) | 49.45 (6.17) | –0.868 | 0.391 | –0.28 |